Ostrich Pharma

Ostrich Pharma is a private biotechnology company developing prophylactic, therapeutic, and consumer health products based on antibodies derived from ostrich eggs. The company appears to operate through a Japanese entity, Ostrich Pharma KK, and a U.S. affiliate, OSTRICH PHARMA USA, INC., which uses the trade name OstriGen. Its platform centers on ostrich IgY antibodies designed for infectious disease prevention and treatment, with disclosed work spanning gastrointestinal pathogens, SARS-CoV-2, norovirus, and Ebola, as well as a consumer hair-growth product called OstriGrow. Publicly visible evidence points mainly to patent activity, early product marketing, and preclinical or exploratory development rather than an advanced clinical-stage pipeline. The company is best understood as an antibody-platform business at the intersection of biotech, infectious disease prophylaxis, and health products.